PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE BETA-GALACTOSIDASE (RHGALC)
申请人:Ace Biosciences A/S
公开号:EP2920198A1
公开(公告)日:2015-09-23
PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE B-GALACTOSIDASE (rhGALC)
申请人:ACE BIOSCIENCES A/S
公开号:US20150284698A1
公开(公告)日:2015-10-08
The present invention relates to a process for purifying recombinant human Galactocerebroside β-Galactosidase dase (rhGALC) from a cell culture, wherein a fraction of said cell culture comprising rhGALC is subjected to chromatography on three distinct resins.
[EN] TREATING PROTEIN MISFOLDING DISEASES<br/>[FR] TRAITEMENT DES PATHOLOGIES DE MAUVAIS REPLIEMENT DES PROTÉINES
申请人:MAYO FOUNDATION
公开号:WO2009061906A2
公开(公告)日:2009-05-14
This document provides methods and materials related to treating a protein misfolding disease. For example, methods and materials relating to the use of a lobeline compound to treat a protein misfolding disease are provided.
[EN] PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE &bgr;-GALACTOSIDASE (rhGALC)<br/>[FR] PURIFICATION DE GALACTOCÉREBROSIDE &Bgr;-GALACTOSIDASE HUMAINE RECOMBINANTE (RHGALC)
申请人:ACE BIOSCIENCES AS
公开号:WO2014075688A1
公开(公告)日:2014-05-22
The present invention relates to a process for purifying recombinant human Galactocerebroside β-Galactosidase (rhGALC) from a cell culture, wherein a fraction of said cell culture comprising rhGALC is subjected to chromatography on three distinct resins.